NeoGenomics (NEO) closed the last trading session at $14, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $21.18 indicates a 51.3% upside potential.The average comprises 11 short-term price targets ranging from a low of $18 to a high of $30, with a standard deviation of $3.74. While the lowest estimate indicates an increase of 28.6% from the current price level, the mo ...